Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Mural Oncology plc - Ordinary Shares (NQ:MURA)

2.040 UNCHANGED
Last Price Updated: 4:00 PM EST, Dec 4, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Mural Oncology plc - Ordinary Shares

< Previous 1 2 3 4 Next >
News headline image
MURA Stock Earnings: Mural Oncology Beats EPS for Q2 2024 ↗
MURA stock results show that Mural Oncology beat analyst estimates for earnings per share the second quarter of 2024. 
Via InvestorPlace
News headline image
Mural Oncology Announces Second Quarter 2024 Financial Results and Provides Update on Pipeline Progress
From Mural Oncology, Inc.
Via GlobeNewswire
News headline image
Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Mural Oncology, Inc.
Via GlobeNewswire
News headline image
Mural Oncology Appoints Veteran Business Development Executive George Golumbeski, Ph.D., to its Board of Directors
From Mural Oncology, Inc.
Via GlobeNewswire
News headline image
MURA Stock Earnings: Mural Oncology Reported Results for Q1 2024 ↗
Mural Oncology just reported results for the first quarter of 2024. 
Via InvestorPlace
News headline image
MURA Stock Earnings: Mural Oncology Reported Results for Q4 2023 ↗
Mural Oncology just reported results for the fourth quarter of 2023. 
Via InvestorPlace
News headline image
Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Mural Oncology, Inc.
Via GlobeNewswire
News headline image
Mural to Present and Host 1x1 Investor Meetings at the 14th Annual East Coast IDEAS Investor Conference
From Mural Oncology, Inc.
Via GlobeNewswire
News headline image
Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Mural Oncology, Inc.
Via GlobeNewswire
News headline image
MURA Stock Earnings: Mural Oncology Reported Results for Q3 2023 ↗
Mural Oncology just reported results for the third quarter of 2023. 
Via InvestorPlace
News headline image
Mural Oncology Presents Clinical Data from ARTISTRY-3 at the American Society of Clinical Oncology Annual Meeting
From Mural Oncology, Inc.
Via GlobeNewswire
News headline image
Mural Oncology Announces First Quarter 2024 Financial Results and Provides Business Update
From Mural Oncology, Inc.
Via GlobeNewswire
News headline image
Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Mural Oncology, Inc.
Via GlobeNewswire
News headline image
Mural Oncology Announces Upcoming Presentation at 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
From Mural Oncology, Inc.
Via GlobeNewswire
News headline image
Mural Oncology Presents Preclinical Data for IL-18 and IL-12 Programs at the 2024 American Association for Cancer Research Annual Meeting
From Mural Oncology, Inc.
Via GlobeNewswire
News headline image
Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Mural Oncology, Inc.
Via GlobeNewswire
News headline image
Mural Oncology Announces Fourth Quarter and Year End 2023 Financial Results and Provides Business Update
From Mural Oncology, Inc.
Via GlobeNewswire
News headline image
Mural Oncology Announces Upcoming Presentations at 2024 American Association for Cancer Research (AACR) Annual Meeting
From Mural Oncology, Inc.
Via GlobeNewswire
News headline image
Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Mural Oncology, Inc.
Via GlobeNewswire
News headline image
Mural Oncology to Present at the TD Cowen 44th Annual Health Care Conference
From Mural Oncology, Inc.
Via GlobeNewswire
News headline image
Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Mural Oncology, Inc.
Via GlobeNewswire
News headline image
The 3 Best Biotech Stocks to Invest in for Big Gains in 2024 ↗
These pivotal biotech stocks for gains are charting the future of medicine and investment growth in 2024 offering powerful returns 
Via InvestorPlace
News headline image
The 3 Most Undervalued Biotech Stocks to Buy in January ↗
These are a number of undervalued biotech companies that investor should possibly look to add to their portfolios. 
Via InvestorPlace
News headline image
Mural Oncology Announces Enhancements to Late-Stage Clinical Trials
From Mural Oncology, Inc.
Via GlobeNewswire
News headline image
Why Applied UV Shares Are Trading Higher By Around 96%; Here Are 20 Stocks Moving Premarket ↗
Shares of Applied UV, Inc. (NASDAQ: AUVI) shares jumped in pre-market trading after the company reported third-quarter results. 
Via Benzinga
News headline image
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday ↗
It's time to start the week with a breakdown of the biggest pre-market stock movers traders need to watch on Monday morning! 
Via InvestorPlace
News headline image
Why Dolby Laboratories Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗
Shares of Dolby Laboratories, Inc. (NYSE: DLB) fell during Friday’s session following weak guidance. 
Via Benzinga
News headline image
Dear LI Stock Fans, Mark Your Calendars for Dec. 4 ↗
Li Auto stock fans are preparing for a major catalyst when the company's shares join the Hang Seng Index starting on Dec. 4. 
Via InvestorPlace
News headline image
Why Is ChargePoint (CHPT) Stock Down 32% Today? ↗
ChargePoint stock is falling on Friday as investors in CHPT shares react to preliminary earnings data for the third quarter of the year. 
Via InvestorPlace
News headline image
Why Is Bone Biologics (BBLG) Stock Down 38% Today? ↗
Bone Biologics stock is falling on Friday as shares of BBLG give up some of the gains they saw during an unexpected rally on Thursday! 
Via InvestorPlace
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.